AAIC26: Community co-development to guide next generation of diverse trials

Placing local communities at the heart of clinical trials is the key to unlocking diversity in Alzheimer’s research, experts at AAIC 2026 say Placing local communities at the heart of clinical trials is the key to unlocking true diversity in Alzheimer’s research, experts say. Alzheimer’s researchers in the US are looking to boost the diversity of patient enrolled into clinical trials through community-led initiatives. Credit: Nanzeeba / Shutterstock.com. Despite progress in bolstering the diversity of clinical trials within the Alzheimer’s disease space, significant barriers to true study diversity and representation remain, as marginalised communities continue to contend with inaccessibility or…

Source: Clinical Trials Arena